Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (36)

2021

  1. Systematic Review: Medication Effects on Brain Intrinsic Functional Connectivity in Patients With Attention-Deficit/Hyperactivity Disorder

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 60, Núm. 2, pp. 222-235

2019

  1. Clinical and neuropsychological predictors of methylphenidate response in children and adolescents with adhd: A naturalistic follow-up study in a Spanish sample

    Clinical Practice and Epidemiology in Mental Health, Vol. 15, Núm. 1, pp. 160-171

  2. Normative ADHD-RS-Preschool Data in a Community Sample in Spain

    Journal of Attention Disorders, Vol. 23, Núm. 6, pp. 615-623

  3. Phenomenology and diagnostic stability of paediatric bipolar disorder in a Spanish sample

    Journal of Affective Disorders, Vol. 242, pp. 224-233

  4. Validation of a Spanish-language version of the ADHD Rating Scale IV in a Spanish sample

    Neurologia, Vol. 34, Núm. 9, pp. 563-572

2018

  1. Attention deficit hyperactivity disorder in preschool age children. Its epidemiological prevalence in Navarra and La Rioja, Spain

    Revista de Neurologia, Vol. 66, pp. S115-S120

  2. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

    CNS Drugs, Vol. 32, Núm. 5, pp. 455-467

  3. Practitioner review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 59, Núm. 9, pp. 932-947

2017

  1. Desarrollo psicomotor y dificultades del aprendizaje en preescolares con probable trastorno por déficit de atención e hiperactividad. Estudio epidemiológico en Navarra y La Rioja

    Neurologia, Vol. 32, Núm. 8, pp. 487-493

  2. Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

    CNS Drugs, Vol. 31, Núm. 7, pp. 625-638

  3. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder

    European Child and Adolescent Psychiatry, Vol. 26, Núm. 11, pp. 1283-1307

  4. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate

    Journal of Child and Adolescent Psychopharmacology, Vol. 27, Núm. 8, pp. 723-730

2015

  1. Brain development in adhd: A neuroimaging perspective

    Attention Deficit Hyperactivity Disorder (ADHD): Epidemiology, Treatment and Prevention (Nova Science Publishers, Inc.), pp. 257-272

  2. Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder

    European Neuropsychopharmacology, Vol. 25, Núm. 10, pp. 1611-1621

2014

  1. Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/ hyperactivity disorder in a randomized, Controlled trial

    Neuropsychiatric Disease and Treatment, Vol. 10, pp. 2039-2047

2013

  1. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents

    CNS Drugs, Vol. 27, Núm. 9, pp. 743-751

  2. Bases para la elección del tratamiento farmacológico en el trastorno por déficit de atención/hiperactividad

    Revista de Neurologia, Vol. 56, Núm. SUPPL. 1

  3. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

    European Neuropsychopharmacology, Vol. 23, Núm. 10, pp. 1208-1218

  4. Evaluating internet information on attention- deficit/hyperactivity disorder (ADHD) treatment: Parent and expert perspectives

    Education for Health: Change in Learning and Practice, Vol. 26, Núm. 1, pp. 48-53

  5. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder

    CNS Drugs, Vol. 27, Núm. 10, pp. 829-840